-
1
-
-
0037433652
-
Down's syndrome
-
[1] Roizen, N.J., Patterson, D., Down's syndrome. Lancet 361 (2003), 1281–1289.
-
(2003)
Lancet
, vol.361
, pp. 1281-1289
-
-
Roizen, N.J.1
Patterson, D.2
-
2
-
-
84860330689
-
Neurological phenotypes for Down syndrome across the life span
-
[2] Lott, I.T., Neurological phenotypes for Down syndrome across the life span. Prog Brain Res 197 (2012), 101–121.
-
(2012)
Prog Brain Res
, vol.197
, pp. 101-121
-
-
Lott, I.T.1
-
3
-
-
0023889961
-
The pathological association between Down syndrome and Alzheimer disease
-
[3] Mann, D.M., The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 43 (1988), 99–136.
-
(1988)
Mech Ageing Dev
, vol.43
, pp. 99-136
-
-
Mann, D.M.1
-
4
-
-
0022919237
-
The topography of plaques and tangles in Down's syndrome patients of different ages
-
[4] Mann, D.M., Yates, P.O., Marcyniuk, B., Ravindra, C.R., The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol Appl Neurobiol 12 (1986), 447–457.
-
(1986)
Neuropathol Appl Neurobiol
, vol.12
, pp. 447-457
-
-
Mann, D.M.1
Yates, P.O.2
Marcyniuk, B.3
Ravindra, C.R.4
-
5
-
-
0021956826
-
Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome
-
[5] Wisniewski, K.E., Wisniewski, H.M., Wen, G.Y., Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17 (1985), 278–282.
-
(1985)
Ann Neurol
, vol.17
, pp. 278-282
-
-
Wisniewski, K.E.1
Wisniewski, H.M.2
Wen, G.Y.3
-
6
-
-
0002849850
-
Aging and Alzheimer's disease in Down syndrome: Clinical and pathological changes
-
[6] Zigman, W., Silverman, W., Wisniewski, H.M., Aging and Alzheimer's disease in Down syndrome: Clinical and pathological changes. Ment Retard Dev Disabil Res Rev 2 (1996), 73–79.
-
(1996)
Ment Retard Dev Disabil Res Rev
, vol.2
, pp. 73-79
-
-
Zigman, W.1
Silverman, W.2
Wisniewski, H.M.3
-
7
-
-
0019087230
-
Alzheimer-like cholinergic deficiency in Down syndrome
-
[7] Yates, C.M., Simpson, J., Maloney, A.F., Gordon, A., Reid, A.H., Alzheimer-like cholinergic deficiency in Down syndrome. Lancet, 2, 1980, 979.
-
(1980)
Lancet
, vol.2
, pp. 979
-
-
Yates, C.M.1
Simpson, J.2
Maloney, A.F.3
Gordon, A.4
Reid, A.H.5
-
8
-
-
0021827834
-
Abnormalities of the nucleus basalis in Down's syndrome
-
[8] Casanova, M.F., Walker, L.C., Whitehouse, P.J., Price, D.L., Abnormalities of the nucleus basalis in Down's syndrome. Ann Neurol 18 (1985), 310–313.
-
(1985)
Ann Neurol
, vol.18
, pp. 310-313
-
-
Casanova, M.F.1
Walker, L.C.2
Whitehouse, P.J.3
Price, D.L.4
-
9
-
-
0030022841
-
Prevalence of dementia in adults with and without Down syndrome
-
[9] Zigman, W.B., Schupf, N., Sersen, E., Silverman, W., Prevalence of dementia in adults with and without Down syndrome. Am J Ment Retard 100 (1996), 403–412.
-
(1996)
Am J Ment Retard
, vol.100
, pp. 403-412
-
-
Zigman, W.B.1
Schupf, N.2
Sersen, E.3
Silverman, W.4
-
10
-
-
58649091967
-
Alzheimer's Disease in Adults with Down Syndrome
-
[10] Zigman, W.B., Devenny, D.A., Krinsky-McHale, S.J., Jenkins, E.C., Urv, T.K., Wegiel, J., et al. Alzheimer's Disease in Adults with Down Syndrome. Int Rev Res Ment Retard 36 (2008), 103–145.
-
(2008)
Int Rev Res Ment Retard
, vol.36
, pp. 103-145
-
-
Zigman, W.B.1
Devenny, D.A.2
Krinsky-McHale, S.J.3
Jenkins, E.C.4
Urv, T.K.5
Wegiel, J.6
-
11
-
-
0024370171
-
A prospective study of Alzheimer disease in Down syndrome
-
[11] Lai, F., Williams, R.S., A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46 (1989), 849–853.
-
(1989)
Arch Neurol
, vol.46
, pp. 849-853
-
-
Lai, F.1
Williams, R.S.2
-
12
-
-
0035671551
-
Dementia in people with Down's syndrome
-
[12] Tyrrell, J., Cosgrave, M., McCarron, M., McPherson, J., Calvert, J., Kelly, A., et al. Dementia in people with Down's syndrome. Int J Geriatr Psychiatry 16 (2001), 1168–1174.
-
(2001)
Int J Geriatr Psychiatry
, vol.16
, pp. 1168-1174
-
-
Tyrrell, J.1
Cosgrave, M.2
McCarron, M.3
McPherson, J.4
Calvert, J.5
Kelly, A.6
-
13
-
-
38049179307
-
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
-
[13] Hampel, H., Burger, K., Teipel, S.J., Bokde, A.L., Zetterberg, H., Blennow, K., Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement 4 (2008), 38–48.
-
(2008)
Alzheimers Dement
, vol.4
, pp. 38-48
-
-
Hampel, H.1
Burger, K.2
Teipel, S.J.3
Bokde, A.L.4
Zetterberg, H.5
Blennow, K.6
-
14
-
-
84863224067
-
Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot
-
[14] Hampel, H., Lista, S., Khachaturian, Z.S., Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot. Alzheimers Dement 8 (2012), 312–336.
-
(2012)
Alzheimers Dement
, vol.8
, pp. 312-336
-
-
Hampel, H.1
Lista, S.2
Khachaturian, Z.S.3
-
15
-
-
34447322271
-
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria
-
[15] Dubois, B., Feldman, H.H., Jacova, C., Dekosky, S.T., Barberger-Gateau, P., Cummings, J., et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6 (2007), 734–746.
-
(2007)
Lancet Neurol
, vol.6
, pp. 734-746
-
-
Dubois, B.1
Feldman, H.H.2
Jacova, C.3
Dekosky, S.T.4
Barberger-Gateau, P.5
Cummings, J.6
-
16
-
-
77957951112
-
Revising the definition of Alzheimer's disease: a new lexicon
-
[16] Dubois, B., Feldman, H.H., Jacova, C., Cummings, J.L., Dekosky, S.T., Barberger-Gateau, P., et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 9 (2010), 1118–1127.
-
(2010)
Lancet Neurol
, vol.9
, pp. 1118-1127
-
-
Dubois, B.1
Feldman, H.H.2
Jacova, C.3
Cummings, J.L.4
Dekosky, S.T.5
Barberger-Gateau, P.6
-
17
-
-
79956098248
-
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
[17] Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 (2011), 280–292.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 280-292
-
-
Sperling, R.A.1
Aisen, P.S.2
Beckett, L.A.3
Bennett, D.A.4
Craft, S.5
Fagan, A.M.6
-
18
-
-
84896712004
-
Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?
-
[18] Caraci, F., Castellano, S., Salomone, S., Drago, F., Bosco, P., Di Nuovo, S., Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?. CNS Neurol Disord Drug Targets 13 (2014), 173–186.
-
(2014)
CNS Neurol Disord Drug Targets
, vol.13
, pp. 173-186
-
-
Caraci, F.1
Castellano, S.2
Salomone, S.3
Drago, F.4
Bosco, P.5
Di Nuovo, S.6
-
19
-
-
0023009645
-
Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease
-
[19] Etienne, P., Robitaille, Y., Wood, P., Gauthier, S., Nair, N.P., Quirion, R., Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience 19 (1986), 1279–1291.
-
(1986)
Neuroscience
, vol.19
, pp. 1279-1291
-
-
Etienne, P.1
Robitaille, Y.2
Wood, P.3
Gauthier, S.4
Nair, N.P.5
Quirion, R.6
-
20
-
-
0021059767
-
Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase
-
[20] Pearson, R.C., Sofroniew, M.V., Cuello, A.C., Powell, T.P., Eckenstein, F., Esiri, M.M., et al. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res 289 (1983), 375–379.
-
(1983)
Brain Res
, vol.289
, pp. 375-379
-
-
Pearson, R.C.1
Sofroniew, M.V.2
Cuello, A.C.3
Powell, T.P.4
Eckenstein, F.5
Esiri, M.M.6
-
21
-
-
0024449354
-
Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain
-
[21] Mufson, E.J., Bothwell, M., Kordower, J.H., Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp Neurol 105 (1989), 221–232.
-
(1989)
Exp Neurol
, vol.105
, pp. 221-232
-
-
Mufson, E.J.1
Bothwell, M.2
Kordower, J.H.3
-
22
-
-
0033809884
-
Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease
-
[22] Mufson, E.J., Ma, S.Y., Cochran, E.J., Bennett, D.A., Beckett, L.A., Jaffar, S., et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 427 (2000), 19–30.
-
(2000)
J Comp Neurol
, vol.427
, pp. 19-30
-
-
Mufson, E.J.1
Ma, S.Y.2
Cochran, E.J.3
Bennett, D.A.4
Beckett, L.A.5
Jaffar, S.6
-
23
-
-
0025262384
-
Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease
-
[23] Vogels, O.J., Broere, C.A., ter Laak, H.J., ten Donkelaar, H.J., Nieuwenhuys, R., Schulte, B.P., Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol Aging 11 (1990), 3–13.
-
(1990)
Neurobiol Aging
, vol.11
, pp. 3-13
-
-
Vogels, O.J.1
Broere, C.A.2
ter Laak, H.J.3
ten Donkelaar, H.J.4
Nieuwenhuys, R.5
Schulte, B.P.6
-
24
-
-
0020072221
-
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain
-
[24] Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T., Delon, M.R., Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215 (1982), 1237–1239.
-
(1982)
Science
, vol.215
, pp. 1237-1239
-
-
Whitehouse, P.J.1
Price, D.L.2
Struble, R.G.3
Clark, A.W.4
Coyle, J.T.5
Delon, M.R.6
-
25
-
-
0017133142
-
Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies
-
[25] Bowen, D.M., Smith, C.B., White, P., Davison, A.N., Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99 (1976), 459–496.
-
(1976)
Brain
, vol.99
, pp. 459-496
-
-
Bowen, D.M.1
Smith, C.B.2
White, P.3
Davison, A.N.4
-
26
-
-
0011162190
-
Selective loss of central cholinergic neurons in Alzheimer's disease
-
[26] Davies, P., Maloney, A.J., Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 2, 1976, 1403.
-
(1976)
Lancet
, vol.2
, pp. 1403
-
-
Davies, P.1
Maloney, A.J.2
-
27
-
-
0021264594
-
Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes
-
[27] Mann, D.M., Yates, P.O., Marcyniuk, B., Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 10 (1984), 185–207.
-
(1984)
Neuropathol Appl Neurobiol
, vol.10
, pp. 185-207
-
-
Mann, D.M.1
Yates, P.O.2
Marcyniuk, B.3
-
28
-
-
0033616613
-
A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat
-
[28] Debeir, T., Saragovi, H.U., Cuello, A.C., A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat. Proc Natl Acad Sci U S A 96 (1999), 4067–4072.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 4067-4072
-
-
Debeir, T.1
Saragovi, H.U.2
Cuello, A.C.3
-
29
-
-
0030447321
-
Effects of trophic factors on the CNS cholinergic phenotype
-
[29] Cuello, A.C., Effects of trophic factors on the CNS cholinergic phenotype. Prog Brain Res 109 (1996), 347–358.
-
(1996)
Prog Brain Res
, vol.109
, pp. 347-358
-
-
Cuello, A.C.1
-
30
-
-
69449097269
-
Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease
-
[30] Bruno, M.A., Leon, W.C., Fragoso, G., Mushynski, W.E., Almazan, G., Cuello, A.C., Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease. J Neuropathol Exp Neurol 68 (2009), 857–869.
-
(2009)
J Neuropathol Exp Neurol
, vol.68
, pp. 857-869
-
-
Bruno, M.A.1
Leon, W.C.2
Fragoso, G.3
Mushynski, W.E.4
Almazan, G.5
Cuello, A.C.6
-
31
-
-
73349089956
-
Increased matrix metalloproteinase 9 activity in mild cognitive impairment
-
[31] Bruno, M.A., Mufson, E.J., Wuu, J., Cuello, A.C., Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol 68 (2009), 1309–1318.
-
(2009)
J Neuropathol Exp Neurol
, vol.68
, pp. 1309-1318
-
-
Bruno, M.A.1
Mufson, E.J.2
Wuu, J.3
Cuello, A.C.4
-
32
-
-
84894541662
-
Nerve growth factor metabolic dysfunction in Down's syndrome brains
-
[32] Iulita, M.F., Do Carmo, S., Ower, A.K., Fortress, A.M., Aguilar, L.F., Hanna, M., et al. Nerve growth factor metabolic dysfunction in Down's syndrome brains. Brain 137 (2014), 860–872.
-
(2014)
Brain
, vol.137
, pp. 860-872
-
-
Iulita, M.F.1
Do Carmo, S.2
Ower, A.K.3
Fortress, A.M.4
Aguilar, L.F.5
Hanna, M.6
-
33
-
-
84903318473
-
Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome
-
[33] Iulita, M.F., Cuello, A.C., Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome. Trends Pharmacol Sci 35 (2014), 338–348.
-
(2014)
Trends Pharmacol Sci
, vol.35
, pp. 338-348
-
-
Iulita, M.F.1
Cuello, A.C.2
-
34
-
-
84953455893
-
The NGF metabolic pathway in the CNS and its dysregulation in Down syndrome and Alzheimer's disease
-
[34] Iulita, M.F., Cuello, A.C., The NGF metabolic pathway in the CNS and its dysregulation in Down syndrome and Alzheimer's disease. Curr Alzheimer Res 13 (2016), 53–67.
-
(2016)
Curr Alzheimer Res
, vol.13
, pp. 53-67
-
-
Iulita, M.F.1
Cuello, A.C.2
-
35
-
-
33646241085
-
Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade
-
[35] Bruno, M.A., Cuello, A.C., Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci U S A 103 (2006), 6735–6740.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 6735-6740
-
-
Bruno, M.A.1
Cuello, A.C.2
-
36
-
-
0015965912
-
Human memory and the cholinergic system. A relationship to aging?
-
[36] Drachman, D.A., Leavitt, J., Human memory and the cholinergic system. A relationship to aging?. Arch Neurol 30 (1974), 113–121.
-
(1974)
Arch Neurol
, vol.30
, pp. 113-121
-
-
Drachman, D.A.1
Leavitt, J.2
-
37
-
-
0001360461
-
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
-
[37] Griffin, W.S., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86 (1989), 7611–7615.
-
(1989)
Proc Natl Acad Sci U S A
, vol.86
, pp. 7611-7615
-
-
Griffin, W.S.1
Stanley, L.C.2
Ling, C.3
White, L.4
MacLeod, V.5
Perrot, L.J.6
-
38
-
-
84858208717
-
Neuroinflammation in the aging Down syndrome brain; lessons from Alzheimer's disease
-
[38] Wilcock, D.M., Neuroinflammation in the aging Down syndrome brain; lessons from Alzheimer's disease. Curr Gerontol Geriatr Res, 2012, 2012, 170276.
-
(2012)
Curr Gerontol Geriatr Res
, vol.2012
, pp. 170276
-
-
Wilcock, D.M.1
-
39
-
-
79954486783
-
Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?
-
[39] Ferretti, M.T., Cuello, A.C., Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?. Curr Alzheimer Res 8 (2011), 164–174.
-
(2011)
Curr Alzheimer Res
, vol.8
, pp. 164-174
-
-
Ferretti, M.T.1
Cuello, A.C.2
-
40
-
-
84926370173
-
Neuroinflammation in Alzheimer's disease
-
[40] Heneka, M.T., Carson, M.J., El Khoury, J., Landreth, G.E., Brosseron, F., Feinstein, D.L., et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol 14 (2015), 388–405.
-
(2015)
Lancet Neurol
, vol.14
, pp. 388-405
-
-
Heneka, M.T.1
Carson, M.J.2
El Khoury, J.3
Landreth, G.E.4
Brosseron, F.5
Feinstein, D.L.6
-
41
-
-
33748471099
-
Inflammation in Alzheimer disease: driving force, bystander or beneficial response?
-
[41] Wyss-Coray, T., Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med 12 (2006), 1005–1015.
-
(2006)
Nat Med
, vol.12
, pp. 1005-1015
-
-
Wyss-Coray, T.1
-
42
-
-
84940467398
-
Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease
-
[42] Wilcock, D.M., Hurban, J., Helman, A.M., Sudduth, T.L., McCarty, K.L., Beckett, T.L., et al. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease. Neurobiol Aging 36 (2015), 2468–2474.
-
(2015)
Neurobiol Aging
, vol.36
, pp. 2468-2474
-
-
Wilcock, D.M.1
Hurban, J.2
Helman, A.M.3
Sudduth, T.L.4
McCarty, K.L.5
Beckett, T.L.6
-
43
-
-
84859143780
-
Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology
-
[43] Ferretti, M.T., Allard, S., Partridge, V., Ducatenzeiler, A., Cuello, A.C., Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology. J Neuroinflammation, 9, 2012, 62.
-
(2012)
J Neuroinflammation
, vol.9
, pp. 62
-
-
Ferretti, M.T.1
Allard, S.2
Partridge, V.3
Ducatenzeiler, A.4
Cuello, A.C.5
-
44
-
-
84861183285
-
Intracellular Abeta-oligomers and early inflammation in a model of Alzheimer's disease
-
[44] Ferretti, M.T., Bruno, M.A., Ducatenzeiler, A., Klein, W.L., Cuello, A.C., Intracellular Abeta-oligomers and early inflammation in a model of Alzheimer's disease. Neurobiol Aging 33 (2012), 1329–1342.
-
(2012)
Neurobiol Aging
, vol.33
, pp. 1329-1342
-
-
Ferretti, M.T.1
Bruno, M.A.2
Ducatenzeiler, A.3
Klein, W.L.4
Cuello, A.C.5
-
45
-
-
84903820117
-
Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease
-
[45] Hanzel, C.E., Pichet-Binette, A., Pimentel, L.S., Iulita, M.F., Allard, S., Ducatenzeiler, A., et al. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease. Neurobiol Aging 35 (2014), 2249–2262.
-
(2014)
Neurobiol Aging
, vol.35
, pp. 2249-2262
-
-
Hanzel, C.E.1
Pichet-Binette, A.2
Pimentel, L.S.3
Iulita, M.F.4
Allard, S.5
Ducatenzeiler, A.6
-
46
-
-
0028834682
-
Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture
-
[46] Gottschall, P.E., Yu, X., Bing, B., Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J Neurosci Res 42 (1995), 335–342.
-
(1995)
J Neurosci Res
, vol.42
, pp. 335-342
-
-
Gottschall, P.E.1
Yu, X.2
Bing, B.3
-
47
-
-
0028934085
-
Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes
-
[47] Gottschall, P.E., Yu, X., Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 64 (1995), 1513–1520.
-
(1995)
J Neurochem
, vol.64
, pp. 1513-1520
-
-
Gottschall, P.E.1
Yu, X.2
-
48
-
-
0031889386
-
Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
-
[48] Pagenstecher, A., Stalder, A.K., Kincaid, C.L., Shapiro, S.D., Campbell, I.L., Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152 (1998), 729–741.
-
(1998)
Am J Pathol
, vol.152
, pp. 729-741
-
-
Pagenstecher, A.1
Stalder, A.K.2
Kincaid, C.L.3
Shapiro, S.D.4
Campbell, I.L.5
-
49
-
-
0026660964
-
Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
-
[49] Ogata, Y., Enghild, J.J., Nagase, H., Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267 (1992), 3581–3584.
-
(1992)
J Biol Chem
, vol.267
, pp. 3581-3584
-
-
Ogata, Y.1
Enghild, J.J.2
Nagase, H.3
-
50
-
-
0003515548
-
Dementia Scale for Down Syndrome: Manual
-
Gedye Research and Consulting Vancouver, BC
-
[50] Gedye, A., Dementia Scale for Down Syndrome: Manual. 1995, Gedye Research and Consulting, Vancouver, BC.
-
(1995)
-
-
Gedye, A.1
-
51
-
-
84964050982
-
Screening for Alzheimer's Disease in Downs Syndrome
-
[51] O'Caoimh, R., Clune, Y., Molloy, D.W., Screening for Alzheimer's Disease in Downs Syndrome. J Alzheimers Dis Parkinsonism, S7, 2013.
-
(2013)
J Alzheimers Dis Parkinsonism
, vol.S7
-
-
O'Caoimh, R.1
Clune, Y.2
Molloy, D.W.3
-
52
-
-
0003582141
-
International Statistical Classification of Diseases and Related Health Problems
-
World Health Organization Geneva, Switzerland 2010 ed
-
[52] WHO. International Statistical Classification of Diseases and Related Health Problems. 1992, World Health Organization, Geneva, Switzerland 2010 ed.
-
(1992)
-
-
-
53
-
-
0030752773
-
Diagnosis of dementia in individuals with intellectual disability
-
[53] Aylward, E.H., Burt, D.B., Thorpe, L.U., Lai, F., Dalton, A., Diagnosis of dementia in individuals with intellectual disability. J Intellect Disabil Res 41 (1997), 152–164.
-
(1997)
J Intellect Disabil Res
, vol.41
, pp. 152-164
-
-
Aylward, E.H.1
Burt, D.B.2
Thorpe, L.U.3
Lai, F.4
Dalton, A.5
-
54
-
-
41149105045
-
Maladaptive behaviors related to dementia status in adults with Down syndrome
-
[54] Urv, T.K., Zigman, W.B., Silverman, W., Maladaptive behaviors related to dementia status in adults with Down syndrome. Am J Ment Retard 113 (2008), 73–86.
-
(2008)
Am J Ment Retard
, vol.113
, pp. 73-86
-
-
Urv, T.K.1
Zigman, W.B.2
Silverman, W.3
-
55
-
-
84937022941
-
Dementia diagnostic criteria in Down syndrome
-
[55] Sheehan, R., Sinai, A., Bass, N., Blatchford, P., Bohnen, I., Bonell, S., et al. Dementia diagnostic criteria in Down syndrome. Int J Geriatr Psychiatry 30 (2015), 857–863.
-
(2015)
Int J Geriatr Psychiatry
, vol.30
, pp. 857-863
-
-
Sheehan, R.1
Sinai, A.2
Bass, N.3
Blatchford, P.4
Bohnen, I.5
Bonell, S.6
-
56
-
-
84861939416
-
Mild cognitive impairment identified in older individuals with Down syndrome by reduced telomere signal numbers and shorter telomeres measured in microns
-
[56] Jenkins, E.C., Ye, L., Velinov, M., Krinsky-McHale, S.J., Zigman, W.B., Schupf, N., et al. Mild cognitive impairment identified in older individuals with Down syndrome by reduced telomere signal numbers and shorter telomeres measured in microns. Am J Med Genet B Neuropsychiatr Genet 159B (2012), 598–604.
-
(2012)
Am J Med Genet B Neuropsychiatr Genet
, vol.159B
, pp. 598-604
-
-
Jenkins, E.C.1
Ye, L.2
Velinov, M.3
Krinsky-McHale, S.J.4
Zigman, W.B.5
Schupf, N.6
-
57
-
-
0026628073
-
The Test for Severe Impairment: an instrument for the assessment of patients with severe cognitive dysfunction
-
[57] Albert, M., Cohen, C., The Test for Severe Impairment: an instrument for the assessment of patients with severe cognitive dysfunction. J Am Geriatr Soc 40 (1992), 449–453.
-
(1992)
J Am Geriatr Soc
, vol.40
, pp. 449-453
-
-
Albert, M.1
Cohen, C.2
-
58
-
-
0031711528
-
Cognitive decline in Down syndrome: a validity/reliability study of the test for severe impairment
-
[58] Cosgrave, M.P., McCarron, M., Anderson, M., Tyrrell, J., Gill, M., Lawlor, B.A., Cognitive decline in Down syndrome: a validity/reliability study of the test for severe impairment. Am J Ment Retard 103 (1998), 193–197.
-
(1998)
Am J Ment Retard
, vol.103
, pp. 193-197
-
-
Cosgrave, M.P.1
McCarron, M.2
Anderson, M.3
Tyrrell, J.4
Gill, M.5
Lawlor, B.A.6
-
59
-
-
0023194048
-
The Modified Mini-Mental State (3MS) examination
-
[59] Teng, E.L., Chui, H.C., The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48 (1987), 314–318.
-
(1987)
J Clin Psychiatry
, vol.48
, pp. 314-318
-
-
Teng, E.L.1
Chui, H.C.2
-
60
-
-
0034904401
-
Cognitive assessment of severe dementia: the test for severe impairment (TSI)
-
[60] Appollonio, I., Gori, C., Riva, G.P., Spiga, S., Ferrari, A., Ferrarese, C., et al. Cognitive assessment of severe dementia: the test for severe impairment (TSI). Arch Gerontol Geriatr Suppl 7 (2001), 25–31.
-
(2001)
Arch Gerontol Geriatr Suppl
, vol.7
, pp. 25-31
-
-
Appollonio, I.1
Gori, C.2
Riva, G.P.3
Spiga, S.4
Ferrari, A.5
Ferrarese, C.6
-
61
-
-
0025257612
-
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
-
[61] Hixson, J.E., Vernier, D.T., Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 (1990), 545–548.
-
(1990)
J Lipid Res
, vol.31
, pp. 545-548
-
-
Hixson, J.E.1
Vernier, D.T.2
-
62
-
-
11144354439
-
Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease
-
[62] Anello, G., Gueant-Rodriguez, R.M., Bosco, P., Gueant, J.L., Romano, A., Namour, B., et al. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 15 (2004), 859–861.
-
(2004)
Neuroreport
, vol.15
, pp. 859-861
-
-
Anello, G.1
Gueant-Rodriguez, R.M.2
Bosco, P.3
Gueant, J.L.4
Romano, A.5
Namour, B.6
-
63
-
-
0020989535
-
The biosynthesis and processing of proteins in the mouse 7S nerve growth factor complex
-
[63] Darling, T.L., Petrides, P.E., Beguin, P., Frey, P., Shooter, E.M., Selby, M., et al. The biosynthesis and processing of proteins in the mouse 7S nerve growth factor complex. Cold Spring Harb Symp Quant Biol 48 (1983), 427–434.
-
(1983)
Cold Spring Harb Symp Quant Biol
, vol.48
, pp. 427-434
-
-
Darling, T.L.1
Petrides, P.E.2
Beguin, P.3
Frey, P.4
Shooter, E.M.5
Selby, M.6
-
64
-
-
0034006042
-
Commercial recombinant human beta-nerve growth factor and adult rat dorsal root ganglia contain an identical molecular species of nerve growth factor prohormone
-
[64] Reinshagen, M., Geerling, I., Eysselein, V.E., Adler, G., Huff, K.R., Moore, G.P., et al. Commercial recombinant human beta-nerve growth factor and adult rat dorsal root ganglia contain an identical molecular species of nerve growth factor prohormone. J Neurochem 74 (2000), 2127–2133.
-
(2000)
J Neurochem
, vol.74
, pp. 2127-2133
-
-
Reinshagen, M.1
Geerling, I.2
Eysselein, V.E.3
Adler, G.4
Huff, K.R.5
Moore, G.P.6
-
65
-
-
84941066690
-
A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, alpha2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo
-
[65] Barcelona, P.F., Saragovi, H.U., A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, alpha2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo. Mol Cell Biol 35 (2015), 3396–3408.
-
(2015)
Mol Cell Biol
, vol.35
, pp. 3396-3408
-
-
Barcelona, P.F.1
Saragovi, H.U.2
-
66
-
-
84994404215
-
-
Early and late inflammation in Alzheimer's pathology. 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy Geneva, Switzerland: Neurobiology of Aging;. p. S5.
-
[66] Cuello AC. Early and late inflammation in Alzheimer's pathology. 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy Geneva, Switzerland: Neurobiology of Aging; 2014. p. S5.
-
(2014)
-
-
Cuello, A.C.1
-
67
-
-
32344440522
-
Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease
-
[67] Simard, A.R., Soulet, D., Gowing, G., Julien, J.P., Rivest, S., Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 (2006), 489–502.
-
(2006)
Neuron
, vol.49
, pp. 489-502
-
-
Simard, A.R.1
Soulet, D.2
Gowing, G.3
Julien, J.P.4
Rivest, S.5
-
68
-
-
0032213445
-
Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression
-
[68] Eikelenboom, P., Rozemuller, J.M., van Muiswinkel, F.L., Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression. Exp Neurol 154 (1998), 89–98.
-
(1998)
Exp Neurol
, vol.154
, pp. 89-98
-
-
Eikelenboom, P.1
Rozemuller, J.M.2
van Muiswinkel, F.L.3
-
69
-
-
0023633015
-
Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR
-
[69] McGeer, P.L., Itagaki, S., Tago, H., McGeer, E.G., Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79 (1987), 195–200.
-
(1987)
Neurosci Lett
, vol.79
, pp. 195-200
-
-
McGeer, P.L.1
Itagaki, S.2
Tago, H.3
McGeer, E.G.4
-
70
-
-
84908191011
-
Intracellular Abeta pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study
-
[70] Iulita, M.F., Allard, S., Richter, L., Munter, L.M., Ducatenzeiler, A., Weise, C., et al. Intracellular Abeta pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study. Acta Neuropathol Commun, 2, 2014, 61.
-
(2014)
Acta Neuropathol Commun
, vol.2
, pp. 61
-
-
Iulita, M.F.1
Allard, S.2
Richter, L.3
Munter, L.M.4
Ducatenzeiler, A.5
Weise, C.6
-
71
-
-
0036316012
-
Chemokines and pro-inflammatory cytokines in Down's syndrome: an early marker for Alzheimer-type dementia?
-
[71] Carta, M.G., Serra, P., Ghiani, A., Manca, E., Hardoy, M.C., Del Giacco, G.S., et al. Chemokines and pro-inflammatory cytokines in Down's syndrome: an early marker for Alzheimer-type dementia?. Psychother Psychosom 71 (2002), 233–236.
-
(2002)
Psychother Psychosom
, vol.71
, pp. 233-236
-
-
Carta, M.G.1
Serra, P.2
Ghiani, A.3
Manca, E.4
Hardoy, M.C.5
Del Giacco, G.S.6
-
72
-
-
14844327741
-
Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer's type
-
[72] Licastro, F., Chiappelli, M., Ruscica, M., Carnelli, V., Corsi, M.M., Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer's type. Int J Immunopathol Pharmacol 18 (2005), 165–172.
-
(2005)
Int J Immunopathol Pharmacol
, vol.18
, pp. 165-172
-
-
Licastro, F.1
Chiappelli, M.2
Ruscica, M.3
Carnelli, V.4
Corsi, M.M.5
-
73
-
-
79951701023
-
Transgenic mice as a model of pre-clinical Alzheimer's disease
-
[73] Ferretti, M.T., Partridge, V., Leon, W.C., Canneva, F., Allard, S., Arvanitis, D.N., et al. Transgenic mice as a model of pre-clinical Alzheimer's disease. Curr Alzheimer Res 8 (2011), 4–23.
-
(2011)
Curr Alzheimer Res
, vol.8
, pp. 4-23
-
-
Ferretti, M.T.1
Partridge, V.2
Leon, W.C.3
Canneva, F.4
Allard, S.5
Arvanitis, D.N.6
-
74
-
-
77953020162
-
A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment
-
[74] Leon, W.C., Canneva, F., Partridge, V., Allard, S., Ferretti, M.T., DeWilde, A., et al. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. J Alzheimers Dis 20 (2010), 113–126.
-
(2010)
J Alzheimers Dis
, vol.20
, pp. 113-126
-
-
Leon, W.C.1
Canneva, F.2
Partridge, V.3
Allard, S.4
Ferretti, M.T.5
DeWilde, A.6
-
75
-
-
84938689993
-
The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease
-
[75] Pimentel, L.S., Allard, S., Do Carmo, S., Weinreb, O., Danik, M., Hanzel, C.E., et al. The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease. J Alzheimers Dis 47 (2015), 373–383.
-
(2015)
J Alzheimers Dis
, vol.47
, pp. 373-383
-
-
Pimentel, L.S.1
Allard, S.2
Do Carmo, S.3
Weinreb, O.4
Danik, M.5
Hanzel, C.E.6
-
76
-
-
85026789694
-
Intraneuronal Amyloid Beta Accumulation Disrupts Hippocampal CRTC1-Dependent Gene Expression and Cognitive Function in a Rat Model of Alzheimer Disease
-
[E-pub ahead of print]
-
[76] Wilson, E.N., Abela, A.R., Do Carmo, S., Allard, S., Marks, A.R., Welikovitch, L.A., et al. Intraneuronal Amyloid Beta Accumulation Disrupts Hippocampal CRTC1-Dependent Gene Expression and Cognitive Function in a Rat Model of Alzheimer Disease. Cereb Cortex, 2016 [E-pub ahead of print].
-
(2016)
Cereb Cortex
-
-
Wilson, E.N.1
Abela, A.R.2
Do Carmo, S.3
Allard, S.4
Marks, A.R.5
Welikovitch, L.A.6
-
77
-
-
79960769591
-
Extended results of the Alzheimer's disease anti-inflammatory prevention trial
-
[77] Breitner, J.C., Baker, L.D., Montine, T.J., Meinert, C.L., Lyketsos, C.G., Ashe, K.H., et al. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement 7 (2011), 402–411.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 402-411
-
-
Breitner, J.C.1
Baker, L.D.2
Montine, T.J.3
Meinert, C.L.4
Lyketsos, C.G.5
Ashe, K.H.6
-
78
-
-
84880117155
-
Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis
-
[78] Wilcock, D.M., Griffin, W.S., Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis. J Neuroinflammation, 10, 2013, 84.
-
(2013)
J Neuroinflammation
, vol.10
, pp. 84
-
-
Wilcock, D.M.1
Griffin, W.S.2
-
79
-
-
2942536284
-
Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease
-
[79] Peng, S., Wuu, J., Mufson, E.J., Fahnestock, M., Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 63 (2004), 641–649.
-
(2004)
J Neuropathol Exp Neurol
, vol.63
, pp. 641-649
-
-
Peng, S.1
Wuu, J.2
Mufson, E.J.3
Fahnestock, M.4
-
80
-
-
84856986118
-
Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype
-
[80] Allard, S., Leon, W.C., Pakavathkumar, P., Bruno, M.A., Ribeiro-da-Silva, A., Cuello, A.C., Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype. J Neurosci 32 (2012), 2002–2012.
-
(2012)
J Neurosci
, vol.32
, pp. 2002-2012
-
-
Allard, S.1
Leon, W.C.2
Pakavathkumar, P.3
Bruno, M.A.4
Ribeiro-da-Silva, A.5
Cuello, A.C.6
-
81
-
-
0027988295
-
Nerve growth factor production by lymphocytes
-
[81] Santambrogio, L., Benedetti, M., Chao, M.V., Muzaffar, R., Kulig, K., Gabellini, N., et al. Nerve growth factor production by lymphocytes. J Immunol 153 (1994), 4488–4495.
-
(1994)
J Immunol
, vol.153
, pp. 4488-4495
-
-
Santambrogio, L.1
Benedetti, M.2
Chao, M.V.3
Muzaffar, R.4
Kulig, K.5
Gabellini, N.6
-
82
-
-
0029898913
-
Nerve growth factor is an autocrine survival factor for memory B lymphocytes
-
[82] Torcia, M., Bracci-Laudiero, L., Lucibello, M., Nencioni, L., Labardi, D., Rubartelli, A., et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85 (1996), 345–356.
-
(1996)
Cell
, vol.85
, pp. 345-356
-
-
Torcia, M.1
Bracci-Laudiero, L.2
Lucibello, M.3
Nencioni, L.4
Labardi, D.5
Rubartelli, A.6
-
83
-
-
62649160992
-
Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain
-
[83] Fabbro, S., Seeds, N.W., Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain. J Neurochem 109 (2009), 303–315.
-
(2009)
J Neurochem
, vol.109
, pp. 303-315
-
-
Fabbro, S.1
Seeds, N.W.2
-
84
-
-
0346463111
-
Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains
-
[84] Ledesma, M.D., Abad-Rodriguez, J., Galvan, C., Biondi, E., Navarro, P., Delacourte, A., et al. Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep 4 (2003), 1190–1196.
-
(2003)
EMBO Rep
, vol.4
, pp. 1190-1196
-
-
Ledesma, M.D.1
Abad-Rodriguez, J.2
Galvan, C.3
Biondi, E.4
Navarro, P.5
Delacourte, A.6
-
85
-
-
84901928902
-
Analysis of matrix metallo-proteases and the plasminogen system in mild cognitive impairment and Alzheimer's disease cerebrospinal fluid
-
[85] Hanzel, C.E., Iulita, M.F., Eyjolfsdottir, H., Hjorth, E., Schultzberg, M., Eriksdotter, M., et al. Analysis of matrix metallo-proteases and the plasminogen system in mild cognitive impairment and Alzheimer's disease cerebrospinal fluid. J Alzheimers Dis 40 (2014), 667–678.
-
(2014)
J Alzheimers Dis
, vol.40
, pp. 667-678
-
-
Hanzel, C.E.1
Iulita, M.F.2
Eyjolfsdottir, H.3
Hjorth, E.4
Schultzberg, M.5
Eriksdotter, M.6
-
86
-
-
0032722442
-
The plasminogen (fibrinolytic) system
-
[86] Collen, D., The plasminogen (fibrinolytic) system. Thromb Haemost 82 (1999), 259–270.
-
(1999)
Thromb Haemost
, vol.82
, pp. 259-270
-
-
Collen, D.1
-
87
-
-
77957321489
-
Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease
-
[87] Horstmann, S., Budig, L., Gardner, H., Koziol, J., Deuschle, M., Schilling, C., et al. Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease. Int Psychogeriatr 22 (2010), 966–972.
-
(2010)
Int Psychogeriatr
, vol.22
, pp. 966-972
-
-
Horstmann, S.1
Budig, L.2
Gardner, H.3
Koziol, J.4
Deuschle, M.5
Schilling, C.6
-
88
-
-
0026442957
-
Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders
-
[88] Gijbels, K., Masure, S., Carton, H., Opdenakker, G., Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 41 (1992), 29–34.
-
(1992)
J Neuroimmunol
, vol.41
, pp. 29-34
-
-
Gijbels, K.1
Masure, S.2
Carton, H.3
Opdenakker, G.4
-
89
-
-
78650699283
-
Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review
-
[89] Ramos-Fernandez, M., Bellolio, M.F., Stead, L.G., Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis 20 (2011), 47–54.
-
(2011)
J Stroke Cerebrovasc Dis
, vol.20
, pp. 47-54
-
-
Ramos-Fernandez, M.1
Bellolio, M.F.2
Stead, L.G.3
-
90
-
-
0037418038
-
Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke
-
[90] Montaner, J., Molina, C.A., Monasterio, J., Abilleira, S., Arenillas, J.F., Ribo, M., et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107 (2003), 598–603.
-
(2003)
Circulation
, vol.107
, pp. 598-603
-
-
Montaner, J.1
Molina, C.A.2
Monasterio, J.3
Abilleira, S.4
Arenillas, J.F.5
Ribo, M.6
-
91
-
-
84880746947
-
High MMP-9 activity levels in fragile X syndrome are lowered by minocycline
-
[91] Dziembowska, M., Pretto, D.I., Janusz, A., Kaczmarek, L., Leigh, M.J., Gabriel, N., et al. High MMP-9 activity levels in fragile X syndrome are lowered by minocycline. Am J Med Genet A 161A (2013), 1897–1903.
-
(2013)
Am J Med Genet A
, vol.161A
, pp. 1897-1903
-
-
Dziembowska, M.1
Pretto, D.I.2
Janusz, A.3
Kaczmarek, L.4
Leigh, M.J.5
Gabriel, N.6
-
92
-
-
0033950591
-
Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain
-
[92] Yoshiyama, Y., Asahina, M., Hattori, T., Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain. Acta Neuropathol 99 (2000), 91–95.
-
(2000)
Acta Neuropathol
, vol.99
, pp. 91-95
-
-
Yoshiyama, Y.1
Asahina, M.2
Hattori, T.3
-
93
-
-
33845977715
-
A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation
-
[93] Kim, Y.S., Choi, D.H., Block, M.L., Lorenzl, S., Yang, L., Kim, Y.J., et al. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J 21 (2007), 179–187.
-
(2007)
FASEB J
, vol.21
, pp. 179-187
-
-
Kim, Y.S.1
Choi, D.H.2
Block, M.L.3
Lorenzl, S.4
Yang, L.5
Kim, Y.J.6
-
94
-
-
34447275455
-
Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome
-
[94] Schupf, N., Patel, B., Pang, D., Zigman, W.B., Silverman, W., Mehta, P.D., et al. Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome. Arch Neurol 64 (2007), 1007–1013.
-
(2007)
Arch Neurol
, vol.64
, pp. 1007-1013
-
-
Schupf, N.1
Patel, B.2
Pang, D.3
Zigman, W.B.4
Silverman, W.5
Mehta, P.D.6
-
95
-
-
84947787127
-
Semantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Abeta42 Concentrations in Down Syndrome Young Adults
-
[95] Hoyo, L.D., Xicota, L., Sanchez-Benavides, G., Cuenca-Royo, A., de Sola, S., Langohr, K., et al. Semantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Abeta42 Concentrations in Down Syndrome Young Adults. Front Behav Neurosci, 9, 2015, 301.
-
(2015)
Front Behav Neurosci
, vol.9
, pp. 301
-
-
Hoyo, L.D.1
Xicota, L.2
Sanchez-Benavides, G.3
Cuenca-Royo, A.4
de Sola, S.5
Langohr, K.6
-
96
-
-
84863487378
-
Plasma beta amyloid and the risk of Alzheimer's disease in Down syndrome
-
[96] Coppus, A.M., Schuur, M., Vergeer, J., Janssens, A.C., Oostra, B.A., Verbeek, M.M., et al. Plasma beta amyloid and the risk of Alzheimer's disease in Down syndrome. Neurobiol Aging 33 (2012), 1988–1994.
-
(2012)
Neurobiol Aging
, vol.33
, pp. 1988-1994
-
-
Coppus, A.M.1
Schuur, M.2
Vergeer, J.3
Janssens, A.C.4
Oostra, B.A.5
Verbeek, M.M.6
-
97
-
-
84875250937
-
Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
-
[97] Villemagne, V.L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K.A., Salvado, O., et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol 12 (2013), 357–367.
-
(2013)
Lancet Neurol
, vol.12
, pp. 357-367
-
-
Villemagne, V.L.1
Burnham, S.2
Bourgeat, P.3
Brown, B.4
Ellis, K.A.5
Salvado, O.6
-
98
-
-
80052266213
-
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
-
[98] Karran, E., Mercken, M., De Strooper, B., The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10 (2011), 698–712.
-
(2011)
Nat Rev Drug Discov
, vol.10
, pp. 698-712
-
-
Karran, E.1
Mercken, M.2
De Strooper, B.3
-
99
-
-
0027021888
-
Molecular characterization and measurement of Alzheimer's disease pathology: implications for genetic and environmental aetiology
-
discussion 293–302
-
[99] Wischik, C.M., Harrington, C.R., Mukaetova-Ladinska, E.B., Novak, M., Edwards, P.C., McArthur, F.K., Molecular characterization and measurement of Alzheimer's disease pathology: implications for genetic and environmental aetiology. Ciba Found Symp 169 (1992), 268–293 discussion 293–302.
-
(1992)
Ciba Found Symp
, vol.169
, pp. 268-293
-
-
Wischik, C.M.1
Harrington, C.R.2
Mukaetova-Ladinska, E.B.3
Novak, M.4
Edwards, P.C.5
McArthur, F.K.6
-
100
-
-
77952316871
-
Cognitive deficits and associated neurological complications in individuals with Down's syndrome
-
[100] Lott, I.T., Dierssen, M., Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol 9 (2010), 623–633.
-
(2010)
Lancet Neurol
, vol.9
, pp. 623-633
-
-
Lott, I.T.1
Dierssen, M.2
-
101
-
-
85074109354
-
The Down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in Down syndrome
-
[101] Rafii, M.S., Wishnek, H., Brewer, J.B., Donohue, M.C., Ness, S., Mobley, W.C., et al. The Down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in Down syndrome. Front Behav Neurosci, 9, 2015, 239.
-
(2015)
Front Behav Neurosci
, vol.9
, pp. 239
-
-
Rafii, M.S.1
Wishnek, H.2
Brewer, J.B.3
Donohue, M.C.4
Ness, S.5
Mobley, W.C.6
-
102
-
-
84907055448
-
Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?
-
[102] Rafii, M.S., Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?. Alzheimers Res Ther, 6, 2014, 60.
-
(2014)
Alzheimers Res Ther
, vol.6
, pp. 60
-
-
Rafii, M.S.1
-
103
-
-
84907063733
-
Con: are we ready to translate Alzheimer's disease-modifying therapies to people with Down syndrome?
-
[103] Head, E., Schmitt, F.A., Con: are we ready to translate Alzheimer's disease-modifying therapies to people with Down syndrome?. Alzheimers Res Ther, 6, 2014, 61.
-
(2014)
Alzheimers Res Ther
, vol.6
, pp. 61
-
-
Head, E.1
Schmitt, F.A.2
|